Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review

Review of 33 studies (1 RCT, 5 observational cohorts and 27 case series, total n=594) concludes that the evidence for DOACs in cerebral venous thrombosis is limited, but suggests sufficient safety and efficacy vs standard therapy. Further rigorous trials are needed.

Source:

BMJ Open